Jae-Cheol Jo Selected Research

Jae-Cheol Jo Research Topics

Disease

21	Multiple Myeloma 03/2022 - 02/2011
11	Neoplasms (Cancer) 01/2022 - 12/2007
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 01/2014
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 01/2016
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2014
8	Lymphoma (Lymphomas) 09/2021 - 09/2015
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2020 - 01/2008
4	Febrile Neutropenia 10/2022 - 01/2019
4	Neutropenia 10/2022 - 04/2014
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2007
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 10/2019
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 08/2018
2	Infections 10/2022 - 03/2022
2	Bronchiolitis Obliterans Syndrome 02/2021 - 01/2016
2	Acute Promyelocytic Leukemia 10/2018 - 01/2015
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Disease Progression 08/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2021
1	Osteoporosis 01/2021
1	Leukemia 01/2021
1	Frailty 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 02/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Anemia 11/2019
1	Amyloidosis 09/2019
1	Amyloid Plaque 09/2019
1	Paraproteinemias (Monoclonal Gammopathy) 09/2019
1	Inguinal Hernia (Direct Inguinal Hernia) 02/2019

Drug/Important Bio-Agent (IBA)

10	Dexamethasone (Maxidex)FDA LinkGeneric 08/2021 - 02/2011
9	4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- trifluoromethylphenyl)- 3- (4- pyrazin- 2- ylpyrimidin- 2- ylamino)benzamideIBA 01/2022 - 01/2015
6	Rituximab (Mabthera)FDA Link 10/2022 - 09/2017
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 06/2012
6	Bortezomib (Velcade)FDA Link 03/2022 - 12/2018
6	Thalidomide (Thalomid)FDA Link 01/2021 - 02/2011
6	Busulfan (Busulfex)FDA Link 01/2021 - 06/2012
6	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2014
5	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 02/2011
5	Lenalidomide (CC 5013)FDA Link 08/2021 - 01/2019
5	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 06/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 02/2011
4	bcr-abl Fusion ProteinsIBA 12/2020 - 01/2015
3	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 01/2019
3	Melphalan (Alkeran)FDA LinkGeneric 03/2022 - 01/2020
3	Prednisone (Sone)FDA LinkGeneric 03/2022 - 09/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2020
3	Dasatinib (BMS 354825)FDA Link 11/2021 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 06/2016
3	daratumumabIBA 07/2020 - 12/2018
3	Bendamustine Hydrochloride FDA Link 04/2020 - 08/2018
3	fludarabineIBA 09/2017 - 01/2014
2	pegfilgrastim (Neulasta)FDA Link 10/2022 - 10/2022
2	R-CHOP protocolIBA 10/2022 - 01/2019
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021 - 11/2016
2	carfilzomibIBA 08/2021 - 07/2020
2	Monoclonal AntibodiesIBA 07/2020 - 12/2018
2	Ferritins (Ferritin)IBA 04/2020 - 09/2015
2	Erythropoietin FDA Link 11/2019 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2014
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2017 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 09/2017
2	Tyrosine Kinase InhibitorsIBA 06/2017 - 10/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 09/2015
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 10/2022
1	Levofloxacin (Levaquin)FDA Link 03/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2021
1	S-1 plus cisplatinIBA 01/2021
1	FHDIBA 01/2021
1	ibrutinibIBA 01/2021
1	Carmustine (FIVB)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Alkylating AgentsIBA 07/2020
1	pomalidomideIBA 07/2020
1	elotuzumabIBA 07/2020
1	ixazomibIBA 07/2020
1	PanobinostatIBA 07/2020
1	Immunomodulating AgentsIBA 07/2020
1	Proteasome InhibitorsIBA 07/2020
1	Methylprednisolone FDA LinkGeneric 02/2020
1	temsirolimus FDA Link 01/2020
1	10-propargyl-10-deazaaminopterin FDA Link 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	HematinicsIBA 11/2019
1	Immunoglobulin M (IgM)IBA 09/2019
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 09/2019
1	Cyclin B1IBA 05/2019
1	Polo-Like Kinase 1IBA 05/2019
1	Aurora Kinase AIBA 05/2019
1	Aurora Kinase BIBA 05/2019
1	Aurora KinasesIBA 05/2019
1	TubulinIBA 05/2019
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 05/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2019

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 10/2022 - 06/2007
13	Stem Cell Transplantation 01/2021 - 01/2008
12	Therapeutics 03/2022 - 02/2016
4	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 06/2016
2	Hematopoietic Stem Cell Transplantation 01/2021 - 09/2020
2	Cell Transplantation 09/2017 - 01/2016
2	Induction Chemotherapy 01/2016 - 09/2015